(Reuters) – Private equity firm Carlyle Group Inc says it has invested more than $250 million in Pharmapacks, a U.S. e-commerce firm focused on health, personal care and beauty products. Carlyle’s investment, which values Pharmapacks at about $1.1 billion, comes as the COVID-19 pandemic has pushed more consumers to shop online.
Carlyle invests $250 million in U.S. e-commerce firm Pharmapacks
This entry was posted in Syndicated. Bookmark the permalink.
